Literature DB >> 22454885

Effect of angiotensin-converting enzyme inhibitor on response of plasma renin activity and aldosterone to tilting in man.

J G Collier1, J S Jenkins, J Keddie, M U Khan, B F Robinson.   

Abstract

1 The effect of an angiotensin-converting enzyme inhibitor (SQ 20,881; 0.5 mg/kg) on the response to tilting of plasma renin activity (PRA), plasma aldosterone and cortisol was studied in five normal subjects. 2 PRA rose significantly in both the supine and upright positions following administration of SQ 20,881; no significant effect on aldosterone or cortisol was observed.

Entities:  

Year:  1974        PMID： 22454885      PMCID： PMC1402432          DOI： 10.1111/j.1365-2125.1974.tb00259.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  10 in total

1.  A SIMPLE METHOD FOR IMPROVING THE SPECIFICITY OF THE FLUORIMETRIC DETERMINATION OF ADRENAL CORTICOSTEROIDS IN HUMAN PLASMA.

Authors:  J SPENCER PEET; J R DALY; V SMITH
Journal:  J Endocrinol       Date:  1965-02       Impact factor: 4.286

2.  Rapid marked increase in plasma renin in rats treated with inhibitors of the renin system. Effects of 1-sar-8-ala-angiotensin II and of a synthetic converting enzyme inhibitor (nonapeptide, SQ 20.881) on normal and adrenalectomized rats.

Authors:  J Bing
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-05

3.  Aldosterone secretion in anephric patients.

Authors:  S Mitra; S M Genuth; L B Berman; V Vertes
Journal:  N Engl J Med       Date:  1972-01-13       Impact factor: 91.245

4.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

5.  Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure.

Authors:  H R Brunner; H Gavras; J H Laragh
Journal:  Lancet       Date:  1973-11-10       Impact factor: 79.321

6.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

7.  A diurnal rhythm in plasma renin activity in man.

Authors:  R D Gordon; L K Wolfe; D P Island; G W Liddle
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

8.  Effect of posture on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in man.

Authors:  H M Balikian; A H Brodie; S L Dale; J C Melby; J F Tait
Journal:  J Clin Endocrinol Metab       Date:  1968-11       Impact factor: 5.958

9.  A radioimmunoassay for aldosterone in human peripheral plasma including a comparison of alternate techniques.

Authors:  T Ito; J Woo; R Haning; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1972-01       Impact factor: 5.958

10.  Inhibition of angiotensin conversion in experimental renovascular hypertension.

Authors:  E D Miller; A I Samuels; E Haber; A C Barger
Journal:  Science       Date:  1972-09-22       Impact factor: 47.728
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.